XML 24 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2021       102,959 102,959                
Beginning balance at Dec. 31, 2021 $ 295,913 $ (13,910) $ 282,003 $ 103 $ 103 $ 2,387,039 $ (32,249) $ 2,354,790 $ (2,087,957) $ 18,339 $ (2,069,618) $ (3,272) $ (3,272)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 28,182               28,182        
Other comprehensive income (loss), net of tax (6,414)                     (6,414)  
Issuance of common stock under stock option, award and purchase plans, net (in shares)       3,601                  
Issuance of common stock under stock option, award and purchase plans, net 791     $ 4   787              
Repurchase of common stock (in shares)       (571)                  
Repurchase of common stock (5,134)     $ (1)         (5,133)        
Stock-based compensation $ 25,078         25,078              
Issuance of common stock upon conversion of Notes (in shares) 3,882     3,882                  
Issuance of common stock upon conversion of 2022 and 2024 Notes $ 0     $ 4   (4)              
Ending balance (in shares) at Dec. 31, 2022       109,871                  
Ending balance at Dec. 31, 2022 324,506     $ 110   2,380,651     (2,046,569)     (9,686)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 83,994               83,994        
Other comprehensive income (loss), net of tax 3,980                     3,980  
Issuance of common stock under stock option, award and purchase plans, net (in shares)       2,536                  
Issuance of common stock under stock option, award and purchase plans, net (2,935)     $ 2   (2,937)              
Stock-based compensation $ 27,329         27,329              
Issuance of common stock upon conversion of Notes (in shares) 0                        
Ending balance (in shares) at Dec. 31, 2023 112,407     112,407                  
Ending balance at Dec. 31, 2023 $ 436,874     $ 112   2,405,043     (1,962,575)     (5,706)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 39,217               39,217        
Other comprehensive income (loss), net of tax (8,391)                     (8,391)  
Issuance of common stock under stock option, award and purchase plans, net (in shares)       2,159                  
Issuance of common stock under stock option, award and purchase plans, net $ (886)     $ 2   (888)              
Repurchase of common stock (in shares) (2,400)     (2,409)                  
Repurchase of common stock $ (30,049)     $ (2)         (30,047)        
Excise tax on share repurchases (90)               (90)        
Stock-based compensation $ 28,635         28,635              
Issuance of common stock upon conversion of Notes (in shares) 4,578     4,578                  
Issuance of common stock upon conversion of 2022 and 2024 Notes $ (52)     $ 5   (57)              
Ending balance (in shares) at Dec. 31, 2024 116,735     116,735                  
Ending balance at Dec. 31, 2024 $ 465,258     $ 117   $ 2,432,733     $ (1,953,495)     $ (14,097)